Xylem, Inc.

  • Market Cap: Mid Cap
  • Industry: Industrial Manufacturing
  • ISIN: US98419M1009
USD
140.87
-0.02 (-0.01%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Xylem, Inc. stock-summary
stock-summary
Xylem, Inc.
Industrial Manufacturing
Xylem Inc. is a water technology company. The Company designs, manufactures and services engineered solutions across a range of critical applications. It is an equipment and service provider for water and wastewater applications with a portfolio of products and services addressing the cycle of water, from collection, distribution and use to the return of water to the environment. It has three business segments, which include Water Infrastructure, Applied Water and Sensus. Water Infrastructure focuses on the transportation, treatment and testing of water, offering a range of products, including water and wastewater pumps, and controls and systems. Applied Water serves the uses of water and focuses on the residential, commercial, industrial and agricultural markets. The Sensus segment's products include metering, networked communications, measurement and control technologies, software and services, including cloud-based analytics, remote monitoring and data management.
Company Coordinates stock-summary
Company Details
1 International Dr , RYE BROOK NY : 10573
stock-summary
Tel: 1 914 32357001 914 3235821
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Foreign Institutions

Domestic Funds

Held in 150 Schemes (29.87%)

Foreign Institutions

Held by 445 Foreign Institutions (38.7%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Markos Tambakeras
Independent Chairman of the Board
Mr. Patrick Decker
President, Chief Executive Officer, Director
Ms. Jeanne Beliveau-Dunn
Independent Director
Dr. Curtis Crawford
Independent Director
Mr. Robert Friel
Independent Director
Mr. Jorge Gomez
Independent Director
Ms. Victoria Harker
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
2,303 Million
(Quarterly Results - Jun 2025)
Net Profit:
224 Million
stock-summary
Industry

Industrial Manufacturing

stock-summary
Market cap

USD 36,213 Million (Mid Cap)

stock-summary
P/E

35.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

103.74%

stock-summary
Debt Equity

0.09

stock-summary
Return on Equity

8.72%

stock-summary
Price to Book

3.27